Jump directly to main navigation Jump directly to content

Institute of Novel and Emerging Infectious Diseases (INNT

National Reference Laboratory for Japanese encephalitis virus (JEV)

The Japanese encephalitis virus (JEV), like Dengue-Virus, Yellow fever virus or West Nile fever virus, belongs to the family of Flaviviruses. The genome consists of a single-stranded plus-strand RNA with a size of 11 kb (kilobases). The RNA encodes for 3 structural proteins (capsid-, membrane- and envelope protein) and 7 non-structural proteins (enzymes). The virus can be found in Japan, but also in all temperate and tropical zones of south-east Asiawhere 30.000 to 50.000 human cases are reported each year. Main focuses are rural regions with rice production and pig-breeding, but there are also infections in urban regions of developed Asian countries. Like most arboviruses, Japanese encephalitis is spread by infected mosquitoes. However, a direct transmission between humans is not possible. Domestic animals like horses, pigs and dogs can be infected by the virus, too. More than 95% of human infections proceed without any clinical symptoms, 5% of the cases develop encephalitis (very often with late neurological sequelae) and 0, 5 per cent of these cases end fatal.

So far, Japanese encephalitis virus is still exotic to Germany even though vector competent mosquitoes are present.

The NRL can perform molecular-biological (qRT-PCR) and serological tests (ELISA and VNT) within the scope of free testing or for the clarification of possible differential diagnoses.

  • Antigen- and genome detection in sample material
  • Antibody detection
  • Primary contact for federal, state and European authorities regarding Japanese encephalitis virus diagnostic and control
  • Characterization of virus isolates
  • Review, standardization and enhancement of diagnostic procedures
  • Participation and organization of ring trials (national and international)
  • Collaboration with national and international working groups and participation on research projects
  • Virus isolation and cultivation in vitro
  • Genome detection by RT-PCR (quantitative)
  • Characterization of virus strains by genome sequencing
  • Quantitative analysis of neutralizing antibodies (serum neutralization assays, plaque reduction assays, surrogate assays)
  • Serological analysis of antibodies by ELISA including differentiation of immunoglobulin classes
  • Immunofluorescence-based detection of antibodies (iIFA)
  • Sample material for establishment and validation of novel diagnostic methods (RT-PCR)